Coverage / LON:AVCT / Trade Card

LON:AVCT

Avacta Group Plc

SPECULATIVE BUY 2026-08-01 Updated today 66.50p Healthcare - BiotechnologyAWAIT ENTRY
49

Position levels

Currenttoday
66.50p
Buy <=wait / entry
41.67p
Trim >=take some off
75.00p
Thesis breakA publicly announced Phase I efficacy or safety failure in the lead FAP-activate...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction49 / 100 - SPECULATIVE BUY

Top risks

  • Oversubscribed strategic equity fundraise of GBP 9m
  • Reported 2025 EPS of -GBP 0.09 with revenue of GBP 113k and operating margin of -24,657.52%
  • Analyst consensus median 12-month price target of 72.00 (8.27% upside) with 21 buy/outperform ratings
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.